Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Data Reporting and Recording01:24

Data Reporting and Recording

5.4K
Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.4K
Types of Reports I: Hands-off Report01:25

Types of Reports I: Hands-off Report

1.5K
A hand-off report, also known as a change-of-shift report, is a crucial nursing process that ensures the smooth transition of patient care responsibilities between nursing staff.
Following are the key components and categories of hand-off reports:
Purpose and Process:
1.5K
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

1.2K
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.2K
Types of Reports III: Telephone and Verbal Reports01:26

Types of Reports III: Telephone and Verbal Reports

1.0K
Telephone and Verbal Reports in healthcare settings are two communication methods for conveying therapeutic instructions from healthcare providers to nurses or other healthcare staff.
Here's an overview of each type:
Telephone Orders
1.0K
Reporter Genes02:11

Reporter Genes

13.1K
Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
13.1K
Introduction to Documentation and Reporting01:20

Introduction to Documentation and Reporting

2.9K
Documentation is the systematic process of formally recording, maintaining, and communicating information.
Nursing documentation records essential information and details regarding a patient's care and treatment in written or electronic form. It is a critical aspect of nursing practice that involves documenting assessments, interventions, outcomes, and other relevant details about a patient's health status.
Documentation maps the patient's health journey by creating a comprehensive...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving Compliance With Safe Sleep Guidelines for Vulnerable Patients in a Community Safety Net Hospital Neonatal Intensive Care Unit.

Pediatric quality & safety·2026
Same author

Discordance in amyloid positivity between visual reads and Centiloids: Impact of white matter uptake.

The journal of prevention of Alzheimer's disease·2026
Same author

In-depth Evaluation of the Olink Target 48 Cytokine Panel: Inter-Laboratory Evaluation of Performance and Reliability for Biomarker Studies in Oncology.

The AAPS journal·2026
Same author

Accurate quantification of anti-drug antibodies against each unique Fab of a bispecific antibody using an ECL bridging assay.

Bioanalysis·2026
Same author

Anti-drug Antibody Validation Testing and Reporting Harmonization Addendum.

The AAPS journal·2026
Same author

Assessment of Immune Responses Against AAV Encoded Transgene Products.

The AAPS journal·2026

Related Experiment Video

Updated: Jan 26, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

15.0K

Report on the AAPS Immunogenicity Guidance Forum.

Heather Myler1, Boris Gorovits2, Kelli Phillips3

  • 1Immunochemistry Department, PPD Laboratories, 2244 Dabney Road, Richmond, Virginia, 23230-3323, USA. Heather.Myler@ppdi.com.

The AAPS Journal
|April 18, 2019
PubMed
Summary

This forum discussed immunogenicity testing for therapeutic proteins, focusing on anti-drug antibody (ADA) assay strategies, cut-point assessments, and positive control performance to ensure drug safety and efficacy.

Keywords:
Anti-drug antibodies (ADA)FDA guidanceImmunogenicityNeutralizing antibodies (NAb)

More Related Videos

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

3.0K
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.6K

Related Experiment Videos

Last Updated: Jan 26, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

15.0K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

3.0K
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.6K

Area of Science:

  • Biopharmaceutical Science
  • Drug Development
  • Immunology

Background:

  • The American Association of Pharmaceutical Scientists (AAPS) Annual Guidance Forum convened in September 2018.
  • The forum addressed critical aspects of immunogenicity testing for therapeutic protein products.
  • Key participants included representatives from the pharmaceutical industry and the US Food and Drug Administration (FDA).

Purpose of the Study:

  • To present and discuss updated guidance on immunogenicity testing for therapeutic proteins.
  • To share perspectives from both regulatory agencies (FDA) and the pharmaceutical industry.
  • To deliberate on specific strategies for anti-drug antibody (ADA) assay development and validation.

Main Methods:

  • Discussion-based forum involving experts from industry and regulatory bodies.
  • Presentation of agency and industry viewpoints on current guidance.
  • Focused sessions on critical assay parameters and their assessment.

Main Results:

  • Exploration of strategies for anti-drug antibody (ADA) assay cut-point assessments.
  • Discussion on the selection and performance evaluation of ADA-positive controls (PCs).
  • Consideration of ADA assay attributes, including drug tolerance and sensitivity.

Conclusions:

  • The forum highlighted the importance of robust immunogenicity testing strategies for therapeutic proteins.
  • Consensus and differing perspectives were shared regarding ADA assay cut-point setting and control performance.
  • The discussions aimed to refine best practices for ensuring the safety and efficacy of protein-based therapeutics.